President and CEO of Cvs Health Corp (NYSE:CVS) Larry J Merlo sold 241,150 shares of CVS on 09/13/2017 at an average price of $83.07 a share. The total sale was $20 million.
CVS Health Corp operates in the healthcare sector. Its primary business is that of operating retail pharmacies. CVS Health Corp has a market cap of $84.55 billion; its shares were traded at around $83.17 with a P/E ratio of 16.63 and P/S ratio of 0.48. The dividend yield of CVS Health Corp stocks is 2.33%. CVS Health Corp had annual average EBITDA growth of 11.30% over the past ten years. GuruFocus rated CVS Health Corp the business predictability rank of 4.5-star.
CEO Recent Trades:
President and CEO Larry J Merlo sold 241,150 shares of CVS stock on 09/13/2017 at the average price of $83.07. The price of the stock has increased by 0.12% since.
CFO Recent Trades:
EVP and CFO David M Denton sold 237,078 shares of CVS stock on 09/11/2017 at the average price of $79.65. The price of the stock has increased by 4.42% since.
Directors and Officers Recent Trades:
Director Martin Andrew Burian, bought 2,000 shares of CVS stock on 08/30/2017 at the average price of $0.14. EVP & General Counsel Thomas M Moriarty sold 90,267 shares of CVS stock on 09/11/2017 at the average price of $79.61. The price of the stock has increased by 4.47% since.
For the complete insider trading history of CVS, click here